Test System for Detection of 28 Mutations in the CFTR Gene Using DNA Microchip Hybridization In Vitro — "Cystic Fibrosis-28-Microchip" (TU 21.20.23-261-98539446-2016)

Test System for Detection of 28 Mutations in the CFTR Gene Using DNA Microchip Hybridization In Vitro — "Cystic Fibrosis-28-Microchip" (TU 21.20.23-261-98539446-2016)

Product Name: "Cystic Fibrosis-28-Microchip" test system for identifying 28 mutations in the CFTR gene.

Technical Specifications: TU 21.20.23-261-98539446-2016

Test System Components:

• Amplification Buffer – 1 tube (740 μl)
• Taq DNA Polymerase – 1 tube (110 μl)
• PCR Primer Mix 1 A1 – 1 tube (30 μl)
• PCR Primer Mix 1 A2 – 1 tube (30 μl)
• PCR Primer Mix 1 A3 – 1 tube (30 μl)
• PCR Primer Mix 2 B1 – 1 tube (30 μl)
• PCR Primer Mix 2 B2 – 1 tube (30 μl)
• PCR Primer Mix 2 B3 – 1 tube (30 μl)
• Control Sample (K) – 1 tube (18 μl)
• Deionized Water – 1 bottle (10 ml)
• Hybridization Buffer – 1 bottle (10 ml)
• DNA Microchip in hybridization chamber (Width: 25.0±0.4 mm; Length: 75±1.0 mm; Thickness: 1.01±0.05 mm), in a sealed foil pouch – 5 pcs
• User Manual – 1 pc
• Certificate (Passport) – 1 pc

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Test System for Detection of 28 Mutations in the CFTR Gene Using DNA Microchip Hybridization In Vitro — "Cystic Fibrosis-28-Microchip" (TU 21.20.23-261-98539446-2016), then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.